Home » Stocks » ABMC

American Bio Medica Corp. (ABMC)

Stock Price: $0.0698 USD -0.0002 (-0.29%)
Updated May 14, 2021 3:32 PM EDT - Market closed
Market Cap 2.79M
Revenue (ttm) 4.15M
Net Income (ttm) -796,000
Shares Out 40.00M
EPS (ttm) -0.02
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day May 14
Last Price $0.0698
Previous Close $0.0700
Change ($) -0.0002
Change (%) -0.29%
Day's Open 0.0700
Day's Range 0.0610 - 0.0700
Day's Volume 150,444
52-Week Range 0.0600 - 1.2400

News

There are no news available yet.

About ABMC

American Bio Medica Corporation develops, manufactures, and sells lateral flow immunoassay tests primarily for the immediate detection of drugs in urine and oral fluids. Its drugs detection products in urine include Rapid Drug Screen, a rapid drug test, which detects the presence or absence of 2 to 10 drugs; RDS InCup, a drug-testing cup that detects the presence or absence of 1 to 12 drugs; Rapid TOX, a drug test in a cassette platform, which detects the presence or absence of 1 to 10 drugs; and Rapid TOX Cup II, a drug testing cup that detect... [Read more...]

Industry
Diagnostics & Research
IPO Date
Dec 24, 1997
Stock Exchange
OTCMKTS
Ticker Symbol
ABMC
Full Company Profile

Financial Performance

In 2020, ABMC's revenue was $4.15 million, an increase of 13.46% compared to the previous year's $3.66 million. Losses were -$796,000, 16.9% more than in 2019.

Financial Statements